Schedule item "Naproxen and its salts" was deleted, amended by BC Reg 286/2009 effective November 30, 2009.
Schedule items below were added amended by BC Reg 286/2009 effective November 30, 2009.
| 1 | Acamprosate and its salts |
| 1 | Aliskiren and its salts |
| 1 | Anidulafungin |
| 1 | Aprepitant and its derivatives |
| 1 | Daptomycin |
| 1 | Dasatanib |
| 1 | Deferasirox |
| 1 | Duloxetine and its salts |
| 1 | Inhaled human insulin |
| 1 | Lanreotide and its salts |
| 1 | Lenalidomide |
| 1 | Lumiracoxib |
| 1 | Maraviroc |
| 1 | Micafungin and its salts |
| 1 | Naproxen and its salts (except when sold for oral use with a daily dosage of 440 mg) |
| 2 | Naproxen sodium 220 mg per tablet (when sold in products labeled with a recommended maximum daily dose of 440 mg, and in package sizes exceeding 6 600 mg) |
| 3 | Naproxen sodium 220 mg per tablet (when sold in products labeled with a recommended maximum daily dose of 440 mg, and in package sizes of up to 6 600 mg) |
| 1 | Nicotinic acid when sold in (a) a modified-release oral dosage form that provides 500 mg or more per dosage unit or per daily dose, or (b) an immediate-release oral dosage form that provides more than 500 mg per dosage unit or per daily dose |
| 1 | Oxaliplatin |
| 1 | Paliperidone and its salts and derivatives |
| 1 | Pimobendan |
| 1 | Pirlimycin and its salts |
| 1 | Posaconazole |
| 1 | Raltegravir and its salts |
| 1 | Ranibizumab |
| 1 | Sitaxentan and its salts |
| 1 | Telbivudine |
| 1 | Varenicline and its salts |
| 1 | Ziprasidone and its salts |